Form D · Biotechnology
UTOPIA GROUP, LLC
Loveland, OH · CIK 0001490438
Offering snapshot reported Aug 27, 2014 · SEC filing
- Reported sold
- $129K Offering amount: $130K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Aug 19, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2014 | Initial | $129,056 | No comparison | 9 | SEC filing |
| Apr 29, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-223689
None
Source: Form D, filed Aug 27, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark William Bode | Executive |
| Karen Bode | Director, Executive |
| Axel Zdarsky | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6279 Tri Ridge Blvd., Suite 207,
Loveland, OH, 45140
Loveland, OH, 45140